Mint Medical is on the front lines in the fight against COVID-19, proving that radiology can act as a role model for gathering evidence by utilizing structured data.
In this webcast, Prof. Dr. Maria-Katharina Ganten and Gabriel Salg highlight the urgent need for structured data collection, as well as the importance of data quality, integrity, and traceability. The hosts discuss how to support trial compatible data acquisition in routine work by example of a European multicenter project.
Prof. Ganten and Mr. Salg also provide a look to the future in which radiology has the opportunity to set standards for new research strategies, not only concerning COVID studies but rather for any disease or treatment.
-
37 minute(s)
Clinical trial excellence for routine covid-19 assessment
Related Resources
Related Resources
Heidelberg University Hospital: Key Imaging Features to Distinguish Solid Pseudopapillary Neoplasms from Pancreatic Neuroendocrine Neoplasms
Solid pseudopapillary neoplasms (SPNs), or Frantz tumors, are rare pancreatic tumors accounting for 2-3% of all pancreatic neoplasms. These tumors…
2,237 Patients, 11 Hospitals, four HCC Criteria: A Comparison Study
A recent study, conducted across 11 South Korean hospitals, compared the diagnostic performance of four hepatocellular carcinoma (HCC) diagnostic…
Multicentric Study: Comparison of Diagnostic Guidelines for Hepatocellular Carcinoma
Recent advancements in MRI techniques and tumor biology have led to updated hepatocellular carcinoma (HCC) diagnostic guidelines from various liver…